UK markets closed

HeartBeam, Inc. (BEAT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.9997-0.0603 (-2.93%)
As of 01:23PM EDT. Market open.

HeartBeam, Inc.

2118 Walsh Avenue
Suite 210
Santa Clara, CA 95050
United States
408 899 4443
https://www.heartbeam.com

Sector(s): Healthcare
Industry: Health Information Services
Full-time employees: 15

Key executives

NameTitlePayExercisedYear born
Mr. Richard M. FerrariExecutive Chairman138.59kN/A1954
Dr. Branislav Vajdic Ph.D.Founder, CEO & Director620.6kN/A1955
Mr. Robert P. EnoPresident & Chief Business Officer465.56kN/AN/A
Mr. Kenneth PersenChief Technology Officer378.78kN/AN/A
Dr. Peter J. Fitzgerald FACC, M.D., Ph.D.Member of Scientific Advisory Board & Chief Medical OfficerN/AN/A1958
Ms. Richa GujaratiSenior Vice President of ProductN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

HeartBeam, Inc., a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California.

Corporate governance

HeartBeam, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.